20:25:42 EDT Sun 06 Sep 2026
Enter Symbol
or Name
USA
CA



Q:CERS - CERUS CORP - https://www.cerus.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CERS - Q0.12.40·2.735.12.59+0.020.81,102.52,6105,3272.56  2.60  2.543.4698  1.1719:47:52Jul 3015 min RT 2¢

Recent Trades - Last 10 of 5327
Time ETExPriceChangeVolume
19:47:52Q2.57010.0001100
19:30:02Q2.590.021
16:10:04Q2.590.021
16:10:03Q2.590.021
16:10:03Q2.590.021
16:04:03Q2.590.021
16:04:03Q2.590.021
16:04:03Q2.590.021
16:04:03Q2.590.021
16:01:27Q2.590.022,529

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-07-30 16:01U:CERSNews ReleaseCerus Corporation Announces Second Quarter 2026 Financial Results
2026-07-16 16:01U:CERSNews ReleaseCerus Corporation to Release Second Quarter 2026 Financial Results on July 30, 2026
2026-06-17 08:30U:CERSNews ReleaseCerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress
2026-06-08 08:30U:CERSNews ReleaseCerus Corporation Closes New Debt Facility of Up to $110 Million
2026-04-30 16:01U:CERSNews ReleaseCerus Corporation Announces First Quarter 2026 Financial Results
2026-04-27 08:00U:CERSNews ReleaseCerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood System
2026-04-16 16:01U:CERSNews ReleaseCerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026
2026-03-16 16:05U:CERSNews ReleaseCerus Appoints Vivek Jayaraman as President and Chief Executive Officer
2026-03-02 16:01U:CERSNews ReleaseCerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial Results
2026-02-20 08:30U:CERSNews ReleaseCerus Corporation to Participate in the TD Cowen 46th Annual Health Care Conference
2026-02-17 16:01U:CERSNews ReleaseCerus Corporation to Release Fourth Quarter and Full-Year 2025 Financial Results on March 2, 2026
2026-01-22 07:30U:CERSNews ReleaseDRK Blood Donation Service Baden-Wurttemberg - Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus' INTERCEPT(TM) Blood System in Routine Clinical Practice
2026-01-11 16:00U:CERSNews ReleaseCerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook
2025-12-10 16:15U:CERSNews ReleaseCerus Corporation Announces Group Purchasing Agreement with Blood Centers of America
2025-11-06 16:01U:CERSNews ReleaseCerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance
2025-10-21 08:30U:CERSNews ReleaseCerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual Meeting
2025-10-16 16:00U:CERSNews ReleaseCerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025